MK-677 (Ibutamoren) Guide: Dosage, Benefits & GH/IGF-1 Breakdown

MK-677 (Ibutamoren)

MK-677 (Ibutamoren) is a growth hormone secretagogue studied for its ability to increase growth hormone (GH) and IGF-1 levels. It works by mimicking ghrelin, the body’s hunger hormone, leading to increased GH release, improved recovery, and potential changes in body composition.

How It Works

Ghrelin Receptor Activation ↑ → GH Release ↑ → IGF-1 ↑ → Recovery + Sleep + Growth Support

MK-677 stimulates the ghrelin receptor, which signals the body to increase natural growth hormone secretion. Unlike injectable GH, it works indirectly by enhancing the body’s own production.

Important Distinction

MK-677 is not a peptide.

It is an oral growth hormone secretagogue that works through ghrelin receptor activation.

It does not require reconstitution and is typically taken in capsule or liquid form.

MK-677 Protocol

Standard / Gradual Approach

Week 1–210 mg daily

Week 3–615 mg daily

Week 7+15–25 mg daily

Frequency: Once daily
Timing: Night (most common) or morning depending on goals
Cycle Length: 8–16+ weeks

Real-World vs Clinical Use

Real-World Use

Typical Dose10–25 mg daily

GoalGH support + recovery + sleep

Clinical / Research Context

Studied Dose10–25 mg daily

OutcomeIncreased GH and IGF-1 levels

When & How to Use

• Night dosing is most common (enhances natural GH rhythm)
• Morning dosing may reduce hunger-related side effects
• Take consistently each day
• Often used in longer cycles

Monitoring During Use

• Hunger levels (can increase significantly)
• Sleep quality
• Water retention
• Body composition changes

MK-677 Guide →

Benefits

• Increases GH and IGF-1 levels
• May improve sleep quality
• Supports recovery and muscle growth
• Convenient oral administration

Potential Side Effects

• Increased appetite
• Water retention
• Elevated blood sugar (dose dependent)
• Possible lethargy

Important Notes

• Not a peptide (oral GH secretagogue)
• Does not shut down natural GH production
• Can increase hunger significantly
• Longer use is common vs short cycles

Important Disclaimer

MK-677 is not FDA-approved and is considered a research compound. This content is for educational purposes only.

Browse All Peptides →